Impact of erythromycin resistance on the virulence properties and fitness of Campylobacter jejuni

Microbial Pathogenesis

Volumn 50, Issue 6, 2011, Pages 336-342

  Almofti, Yassir A ^a   Dai, Menghong ^a   Sun, Yawei ^a   Haihong, Hao ^a   Yuan, Zonghui ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

C. jejuni; Ery resistant mutant; Fitness; Virulence

Indexed keywords

ADENINE; AZITHROMYCIN; BILE SALT; CIPROFLOXACIN; CLARITHROMYCIN; CYTOSINE; ERYTHROMYCIN; GENTAMICIN; RNA 23S; TETRACYCLINE; TILMICOSIN; TYLOSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; ERYTHROMYCIN RESISTANCE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; INTRACELLULAR BACTERIUM; MACROPHAGE; MICROBIAL ACTIVITY; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; CAMPYLOBACTER JEJUNI; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GENE DELETION; GENETIC VARIATION; HUMANS; MICE; MICROBIAL SENSITIVITY TESTS; MUTATION; RNA, RIBOSOMAL; VIRULENCE;

CAMPYLOBACTER JEJUNI; MURINAE; MUS;

EID: 80051470074     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2011.02.009     Document Type: Article

References (41)

1. Adak G.K., Meakins S.M., Yip H., Lopman B.A., O'Brien S.J. Disease risks from foods, England and Wales, 1996-2000. Emerg Infect Dis 2005, 11:365-372.
2. Engberg J., Aarestrup F.M., Taylor D.E., Gerner-Smidt P., Nachamkin I. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis 2001, 7:24-34.
3. Young K.T., Davis L.M., Dirita V.J. Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol 2007, 5:665-679.
4. Gibreel A., Taylor D.E. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 2006, 58:243-255.
5. Gibreel A., Kos V.N., Keelan M., Trieber C.A., Levesque S., Michaud S., et al. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob Agents Chemothera 2005, 49:2753-2759.
6. Lin J., Michel L.O., Zhang Q. CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob Agents Chemothera 2002, 46:2124-2131.
7. Cagliero C., Mouline C., Cloeckaert A., Payot S. Synergy between efflux pump Cme-ABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother 2006, 50:3893-3896.
8. Helms M., Simonsen J., Molbak K. Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype typhimurium. J Infect Dis 2004, 190:1652-1654.
9. Martin L.J., Fyfe M., Doré K., Buxton J.A., Pollari F., Henry B., Middleton D., et al. Multi-Provincial Salmonella typhimurium case-control study Steering Committee. Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype typhimurium infections. J Infect Dis 2004, 189:377-384.
10. Varma J., Mlbak K., Barrett T.J., Beebe J.L., Jones T.F., Rabatsky-Ehr T., et al. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis 2005, 191:554-561.
11. Helms M., Simonsen J., Olsen K., Mølbak K. Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registry-based cohort study. J Infect Dis 2005, 191:1050-1055.
12. Taylor D.N., Blaser M.J., Echeverria P., Pitarangsi C., Bodhidatta L., Wang W.L. Erythromycin-resistant Campylobacter infections in Thailand. Antimicrob Agents Chemothera 1987, 31:438-442.
13. Travers K., Barza M. Morbidity of infections caused by antimicrobial- resistant bacteria. Clin Infect Dis 2002, 34(Suppl. 3):S131-S134.
14. Marano N, Vugia D, Fiorentino T, Segler S, Carter M, Kassenborg H, Smith K, Zansky S, Hollinger K, Angulo F, the EIP FoodNet Working Group. Fluoroquinolone-resistant Campylobacter causes longer duration of diarrhea than fluoroquinolone-susceptible Campylobacter strains in FoodNet sites. In: 2nd International Conference on Emerging Infectious Diseases, July 2000 Atlanta, GA.
15. Moore J.E., Barton M.D., Blair I.S., Corcoran D., Dooley J.S.G., Fanning S., et al. The epidemiology of antibiotic resistance in Campylobacter. Microbe Infect 2006, 8:1955-1966.
16. Nelson J.M., Smith K.E., Vugia D.J., Rabatsky-EhrT, Segler S.D., Kassenborg H.D., Zansky S.M., et al. Prolonged diarrhoea due to ciprofloxacin resistant Campylobacter infection. J Infect Dis 2004, 190:1150-1157.
17. Smith K.E., Besser J.M., Hedberg C.W., Leano F.T., Bender J.B., Wicklund J.H., et al. Quinolone- resistant Campylobacter jejuni infections in Minnesota, 1992-1998. N Engl J Med 1999, 340:1525-1532.
18. Bjorkman J., Hughes D., Andersson D.I. Virulence of antibiotic-resistant Salmonella typhimurium. Proc Natl Acad Sci U S A 1998, 95:3949-3953.
19. Giraud E., Brisabois A., Martel J.L., Chaslus-Dancla E. Comparative studies of mutations in animal isolates and experimental in vitro and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob Agents Chemothera 1999, 43:2131-2137.
20. Hao H., Dai M., Wang Y., Peng D., Liu Z., Yuan Z. 23S rRNA mutation A2074C conferring high-level macrolide resistance and fitness cost in Campylobacter jejuni. Microb Drug Resist 2009, 15(4):239-244. 10.1089/mdr.2009.0008.
21. Han F., Pu S., Wang F., Meng J., Ge B. Fitness cost of macrolide resistance in Campylobacter jejuni. Int J Antimicrob Agents 2009, 34(5):462-466.
22. Performance standards for antimicrobial Disk and dilution susceptibility tests for bacteria isolated from animals; Approved standard 2008, Clinical and Laboratory Standards Institute (CLSI), CLSI document, Wayne, PA, M31-A3. 3rd Ed.
23. Performance standards for antimicrobial susceptibility Testing 2006, Clinical and Laboratory Standards Institute (CLSI), Supplement M100-S16, Clinical and Laboratory Standards Institute, Wayne, PA.
24. Ge B., White D.G., McDermott P.F., Girard W., Zhao S., Hubert S., et al. Antimicrobial resistant Campylobacter species from retail raw meats. Appl Enviro Microbiol 2003, 69:3005-3007.
25. Van Deun K., Haesebrouck F., Heyndrickx M., Favoreel H., Dewulf J., Ceelen L., et al. Pasmans F. Virulence properties of Campylobacter jejuni isolates of poultry and human origin. J Med Microbiol 2007, 56:1284-1289.
26. Klancnik A., Guzej B., Jamnik P., Vuckovic D., Abram M., Mozina S.S. Stress response and pathogenic potential of Campylobacter jejuni cells exposed to starvation. Res Microbiol 2009, 160:345-352.
27. Lin A.E., Krastel K., Hobb R.I., Thompson S.A., Cvitkovitch D.G., Gaynor E.C. Atypical roles for Campylobacter jejuni amino acid ATP binding cassette transporter components PaqP and PaqQ in bacterial stress tolerance and pathogen-host cell dynamics. Infect Immun 2009, 77(11):4912-4924.
28. Begley M., Gahan C.G.M., Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev 2005, 29:625-651.
29. Lin J., Sahin O., Michel L.O., Zhang Q. Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect Immun 2003, 71:4250-4259.
30. Ferrero R.L., Lee A. Motility of Campylobacter jejuni in a viscous environment: comparison with conventional rod-shaped bacteria. J Gen Microbiol 1988, 134:53-59.
31. Jin S., Joe A., Lynett J., Hani E.K., Sherman P., Chan V.L. JlpA, a novel surface-exposed lipoprotein specific to Campylobacter jejuni, mediates adherence to host epithelial cells. Mol Microbiol 2001, 39:1225-1236.
32. Konkel M.E., Klena J.D., Rivera-Amill V., Monteville M.R., Biswas D., Raphael B., et al. Secretion of virulence proteins from Campylobacter jejuni is dependent on a functional flagellar export apparatus. J Bacteriol 2004, 186:3296-3303.
33. Song Y.C., Jin S., Louie H., Ng D., Lau R., Zhang Y., et al. FlaC, a protein of Campylobacter jejuni TGH9011 (ATCC43431) secreted through the flagellar apparatus, binds epithelial cells and influences cell invasion. Mol Microbiol 2004, 53:541-553.
34. Binet R., Bowlin A.K., Maurelli A.T., Rank R.G. Impact of azithromycin resistance mutations on the virulence and fitness of Chlamydia caviae in guinea pigs. Antimicro Agents Chemother 2010, 54:1094-1101.
35. Day W.A., Sajecki J.L., Pitts T.M., Joens L.A. Role of catalase in Campylobacter jejuni intracellular survival. Infect Immun 2000, 68:6337-6345.
36. Hickey T.E., Majam G., Guerry P. Intracellular survival of Campylobacter jejuni in human monocytic cells and induction of apoptotic death by cytholethal distending toxin. Infect Immun 2005, 73:5194-5197.
37. Iovine N.M., Pursnani S., Voldman A., Wasserman G., Blaser M.J., Weinrauch Y. Reactive nitrogen species contribute to innate host defense against Campylobacter jejuni. Infect Immun 2008, 76:986-993.
38. Watson R.O., Galán J.E. Campylobacter jejuni survives within epithelial cells by avoiding delivery to lysosomes. PLoS Pathogens 2008, 4(1):e14. 10.1371/journal.ppat.0040014.
39. Andersson D.I. The biological cost of mutational antibiotic resistance: any practical conclusions?. Curr Opin Microbiol 2006, 9:461-465.
40. Zhang Q., Sahin O., McDermott P.F., Payot S. Fitness of antimicrobial-resistant Campylobacter and Salmonella. Microbe Infect 2006, 8:1972-1978.
41. Martínez J.L., Baquero F. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiology Reviews 2002, 15:647-679.